A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC

NCT04316364 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

537

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin
DRUG: SHR-1316、Chemotherapeutic
DRUG: Placebo、Chemotherapeutic

Sponsor

Jiangsu HengRui Medicine Co., Ltd.